FATE THERAPEUTICS INC (FATE)
Latest FATE Insider Trades
- Cindy Tahl - OfficerOpen-market sale$95K
Bahram Valamehr - OfficerOpen-market sale$108K
About FATE THERAPEUTICS INC (FATE)
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
- SAN DIEGO, CA
- 161
- 2013
- XNAS
https://www.fatetherapeutics.comSEC filings for FATE on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 82,747 | $204K |
| Grant or award | 9 | 879,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
FATE Insider Transactions (Form 4)
5331 Form 4 filings on record, the earliest from Dec 16, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cindy Tahl - Officer | Open-market sale | Common Stock | 38,800 |
Recent FATE Form 8-K Filings
5Recent FATE Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Valamehr Bahram | Officer | 43,947 | $108K | View on EDGAR | |
| TAHL CINDY | Officer |
FATE Insider Trading - FAQ
What is the latest insider trade for FATE?
FATE THERAPEUTICS INC (FATE) had 11 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for FATE runs to 31 Form 4 filings, the earliest from 2024-12-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying FATE stock?
No insider purchases of FATE were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling FATE stock?
2 insider sales of FATE were filed in the last 90 days, totaling $204K.
Where can I see FATE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks FATE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow FATE insider buys?
Create a free InsiderAlpha account and press Watch on this page to add FATE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Cindy Tahl view on EDGAR
- - Bahram Valamehr view on EDGAR
- - Redmile Group, LLC view on EDGAR
- - Michael Stewart Lee view on EDGAR
- - Yuan Xu view on EDGAR
- - Karin Jooss view on EDGAR
- - Robert S. Epstein view on EDGAR
- - Shefali Agarwal view on EDGAR
- - Matt Abernethy view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where FATE's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track FATE insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
